Article
Histone deacetylase inhibitors in cancer therapy. A review
21 Nov 2013
Abstract excerpt
BACKGROUND: Despite recent success toward discovery of more effective anticancer drugs, chemoresistance remains a major cause of treatment failure. There is emerging evidence that epigenetics plays a key role in the development of the resistance. Epigenetic regulators such as histone acetyltransferases (HATs) and histone deacetylases (HDACs) play an important role in gene expression. The latter are found to be...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
